Lumexa Imaging Forms Strategic JV With Hospital For Special Surgery To Expand Access To Advanced Outpatient Imaging Services Across New York City Metro Area
Barclays Maintains Overweight on Lumexa Imaging Hldgs, Lowers Price Target to $9
Lumexa Imaging Holdings, Inc. (LMRI) Q1 2026 Earnings Call Transcript
Lumexa Imaging Holdings Inc (NASDAQ:LMRI) Reports Q1 2026 Earnings with Strong EPS Beat While Revenue Falls Slightly Short
Lumexa Imaging Holdings Q1 2026 Earnings Call Transcript
Lumexa Imaging Holdings Sees FY2026 Adj EPS $0.71-$0.77 vs $0.73 Est; Narrows FY2026 Sales Guidance from $1.045B-$1.097B to $1.045B-$1.090B vs $1.067B Est
Lumexa Imaging Holdings Q1 Adj. EPS $0.18 Beats $0.12 Estimate, Sales $252.500M Beat $251.004M Estimate
Barclays Maintains Overweight on Lumexa Imaging Hldgs, Lowers Price Target to $15
Lumexa Imaging Reiterates FY 2026 Guidance
Lumexa Imaging Holdings, Inc. (LMRI) Q4 2025 Earnings Call Transcript
Lumexa Imaging Holdings Inc (NASDAQ:LMRI) Reports Mixed Q4 2025 Results with Revenue Growth but Significant EPS Loss
Lumexa Imaging shares are trading lower after the company reported worse-than-expected Q4 Adj EPS results.
Lumexa Imaging Holdings Sees FY2026 Sales $1.045B-$1.097B vs $1.066B Est
Lumexa Imaging Holdings Q4 Adj. EPS $(0.20) Misses $0.07 Estimate, Sales $267.734M Beat $261.206M Estimate
Lumexa Imaging Holdings, Inc. (LMRI) Presents at Leerink Global Healthcare Conference 2026 - Slideshow
Lumexa Imaging Holdings, Inc. (LMRI) Presents at 47th Annual Raymond James Institutional Investor Conference - Slideshow
Lumexa Imaging Holdings shares are trading higher after Raymond James upgraded the stock from Outperform to Strong Buy rating and announced a $23 price target.
Raymond James Upgrades Lumexa Imaging Holdings to Strong Buy, Announces $23 Price Target
Lumexa Imaging Holdings, Inc. (LMRI) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.